Join to View Full Profile
1635 Aurora CtAurora, CO 80045
Phone+1 720-848-2650
Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Jensen is an endocrinologist based in Aurora, CO and has subspecialties in diabetes and lipid metabolism. He is an alumni of Creighton University School of Medicine and pursued his Fellowship in Endocrinology, Diabetes, and Metabolism at the University of Colorado, following a Residency in Internal Medicine at the Medical College of Wisconsin Affiliated Hospitals. Dr. Jensen has extensive experience in treating conditions such as non-alcoholic fatty liver disease, diabetes, insulin resistance, and both types of diabetes. He has contributed significantly to the medical field with several publications in reputed journals, his work mainly focuses on metabolic dysfunction and related disorders. He has also held the position of Principal Investigator in clinical trials, such as "Copeptin and Nonalcoholic Fatty Liver Disease".
Education & Training
University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 2013 - 2016
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2010 - 2013
Creighton University School of MedicineClass of 2010
Certifications & Licensure
CO State Medical License 2013 - 2027
WI State Medical License 2012 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Copeptin and Nonalcoholic Fatty Liver Disease Start of enrollment: 2018 Jun 19
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsEvolving Role of GLP-1 Therapies in Liver Disease.Mark Lindsay, Gretchen Arndt, Amanda Wieland, Thomas Jensen
Current Gastroenterology Reports. 2025-06-06 - 1 citationsChanges in Transient Elastography with Glucagon-Like Peptide-1 Receptor Agonist Use in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospec...Nazar Akhverdyan, Nazar Akhverdyan, Amanda Wieland, Shelby Sullivan, Mark Lindsay
Metabolic Syndrome and Related Disorders. 2024-10-01 - 15 citationsSweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post-transplant diabetes mellitus and type 2 diabetes mellitus after kid...S Elise Lawrence, Mary Moss Chandran, Jeong M Park, Helen Sweiss, Thomas Jensen
Clinical Transplantation. 2023-03-01
Press Mentions
Colorado Doctors Explain Benefit After Trump Announces Plan to Lower GLP-1 Drug PricesNovember 13th, 2025- Millions of People Suffer From Non-Alcohol Buildup of Fat in the Liver. A Team Approach Offers Critical HelpJune 20th, 2025
Lean NAFLD: An Underrecognized and Challenging Disorder in MedicineJanuary 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
